KATHMANDU: The Department of Drug Administration (DDA) has directed Curex Pharmaceuticals in Kavre to immediately recall a specific batch of its product Enclave OD after laboratory tests found it substandard.

Samples collected during routine market monitoring and analyzed at the National Medicine Laboratory failed to meet required standards.

Citing Section 14 of the Drug Act 1978, the Department has suspended the sale and distribution of batch TEOD-026 and instructed healthcare providers, pharmacies, and the public not to prescribe, sell, distribute, or use the affected medicine.